📰00Replimune Gets Third Try at FDA Approval After Makary Departure - WSJBusiness - Latest - Google News·Replimune Gets Third Try at FDA Approval After Makary Departure - WSJ·3 days ago#ZZws27Hn#wsj#nbsp#font#article#ama#englishlanguage🧰Tag tools✨Add tagReading 0:0015s thresholdBookmarkReplimune Gets Third Try at FDA Approval After Makary Departure WSJReplimune to resubmit twice-rejected drug for approval after FDA shakeup CNBCREPL Stock Shot Up 80% Today – What’s The Deal With FDA? Yahoo FinanceThis Biotech Stock Is Up 85%. FDA Has Agreed to Review a Skin Cancer Drug. Barron'sReplimune to ask FDA for re-review of melanoma drug, as agency stands by past rejections Endpoints News0Read later0Read More